(19)
(11) EP 1 551 789 A1

(12)

(43) Date of publication:
13.07.2005 Bulletin 2005/28

(21) Application number: 03799019.9

(22) Date of filing: 22.09.2003
(51) International Patent Classification (IPC)7C07C 57/26, C07C 51/353, C07C 67/343, C07C 69/608, C07C 229/32, C12P 7/40
(86) International application number:
PCT/IB2003/004179
(87) International publication number:
WO 2004/031115 (15.04.2004 Gazette 2004/16)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 04.10.2002 GB 0223070

(71) Applicants:
  • Pfizer Limited
    Sandwich,Kent CT13 9NJ (GB)

    GB 
  • PFIZER INC.
    New York, N.Y. 10017 (US)

    AT BE BG CH CY CZ DE DK EE ES FI FR GR HU IE IT LU MC NL PT RO SE SI SK TR 

(72) Inventors:
  • GLADWELL, I. R.,c/o Pfizer Global Research & Dev.
    Kent, CT13 9NJ (GB)
  • PETTMAN, A. J.,c/o Pfizer Global Research & Dev.
    Kent CT13 9NJ (GB)

(74) Representative: Rudge, Andrew John 
Pfizer LimitedEuropean Pharma Patent DepartmentRamsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) INTERMEDIATES IN THE PREPARATION OF THERAPEUTIC FUSED BICYCLIC AMINO ACIDS